Type 2 Diabetes Mellitus Clinical Trial
Official title:
Liaoning University of Traditional Chinese Medicine
To investigate the protective effect of calcium dobesilate, Xuefuzhuyu Decoction, calcium dobesilate combined with Xuefuzhuyu Decoction on the early lung function of type 2 diabetes mellitus
Test group and treatment: the patients with type 2 diabetes mellitus were randomly divided
into calcium dobesilate group, Xuefuzhuyu Decoction group and combination group. All
participants were given hypoglycemic, metformin (1000 mg, bid, PO), Mecobalamin Tablets,
nerve nutrition (0.5 mg bid, PO): treatment. Calcium dobesilate group were given
hypoglycemic, metformin (500 mg tid, PO), to improve the circular Calcium Dobesilate
Capsules (0.5 g bid, PO), Mecobalamin Tablets, nerve nutrition (0.5 mg bid, PO): treatment.
Xuefuzhuyu Decoction group was given hypoglycemic, metformin (500 mg tid, PO), to improve
the circular Xuefuzhuyu Decoction (100 ml bid, PO), Mecobalamin Tablets, nerve nutrition
(0.5 mg bid, PO): treatment. The combined treatment group was given metformin hypoglycemic
(500 mg tid, PO), Calcium Dobesilate Capsules, improve circulation (0.5 g bid, PO) +
Xuefuzhuyu Decoction (100 ml, bid, PO), Mecobalamin Tablets, nerve nutrition (0.5 mg bid,
PO). Before treatment, three groups of patients with blood glucose, oxidation related
indicators, retrobulbar hemodynamics and pulmonary function were recorded.
Detection: continuous treatment were observed before and after treatment of the three groups
of patients after 24 weeks of fasting blood glucose (FBG), 2 hour postprandial blood glucose
(2hPBG), body mass index (BMI), peripheral blood glycated hemoglobin (HbA1c) and related
indexes of oxidation, superoxide dismutase (SOD), glutathione peroxidase, Gu Guang (GSH-Px),
reactive oxygen species (ROS) activity, malondialdehyde (MDA) concentration and pulmonary
function, vital capacity (VC%), forced vital capacity (FVC%), one second forced expiratory
flow (FEV1%), peak expiratory flow (PEF%), maximal voluntary ventilation (MVV%), total lung
capacity (TCL%) and a second rate (FEV1/FVC%), diffusion capacity of the lung for carbon
monoxide (DLCO%), lung volume diffusion capacity of carbon monoxide (DLCO/VA%) changes of
the central retinal artery (CRA) and posterior ciliary artery (PCA), eye movement The
changes of blood flow velocity and resistance index (RI) of the pulse (AO) systolic and
diastolic blood flow were recorded.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02771093 -
An Exploratory Study of the Effects of Trelagliptin and Alogliptin on Glucose Variability in Patients With Type 2 Diabetes Mellitus
|
Phase 4 | |
| Completed |
NCT02545842 -
Assessment Study of Three Different Fasting Plasma Glucose Targets in Chinese Patients With Type 2 Diabetes Mellitus (BEYOND III/FPG GOAL)
|
Phase 4 | |
| Recruiting |
NCT03436212 -
Real-Life Home Glucose Monitoring Over 14 Days in T2D Patients With Intensified Therapy Using Insulin Pump.
|
N/A | |
| Completed |
NCT03244800 -
A Study to Investigate Different Doses of 0382 in Overweight and Obese Subjects With Type 2 Diabetes Mellitus.
|
Phase 2 | |
| Completed |
NCT03960424 -
Diabetes Management Program for Hispanic/Latino
|
N/A | |
| Withdrawn |
NCT02769091 -
A Study in Adult Patients With Nonalcoholic Steatohepatitis Who Also Have Type 2 Diabetes
|
Phase 2 | |
| Recruiting |
NCT06065540 -
A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor
|
Phase 3 | |
| Recruiting |
NCT05008276 -
Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study)
|
||
| Completed |
NCT04091373 -
A Study Investigating the Pharmacokinetics of a Single Dose Administration of Cotadutide
|
Phase 1 | |
| Completed |
NCT03296800 -
Study to Evaluate Effects of Probenecid, Rifampin and Verapamil on Bexagliflozin in Healthy Subjects
|
Phase 1 | |
| Recruiting |
NCT06212778 -
Relationship Between Nutritional Status, Hand Grip Strength, and Fatigue in Hospitalized Older Adults With Type 2 Diabetes Mellitus.
|
||
| Completed |
NCT05979519 -
Fresh Carts for Mom's to Improve Food Security and Glucose Management
|
N/A | |
| Recruiting |
NCT05579314 -
XW014 in Healthy Subjects and Patients With Type 2 Diabetes Mellitus (T2DM)
|
Phase 1 | |
| Completed |
NCT03859934 -
Metabolic Effects of Melatonin Treatment
|
Phase 1 | |
| Terminated |
NCT03684642 -
Efficacy and Safety of Efpeglenatide Versus Dulaglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin
|
Phase 3 | |
| Completed |
NCT03248401 -
Effect of Cilostazol on Carotid Atherosclerosis Estimated by 3D Ultrasound in Patients With Type 2 Diabetes
|
Phase 4 | |
| Completed |
NCT03644134 -
A Personalized Intervention to Manage Physiological Stress and Improve Sleep Patterns
|
N/A | |
| Completed |
NCT05295160 -
Fasting-Associated Immune-metabolic Remission of Diabetes
|
N/A | |
| Completed |
NCT02836873 -
Safety and Efficacy of Bexagliflozin in Type 2 Diabetes Mellitus Patients With Moderate Renal Impairment
|
Phase 3 | |
| Completed |
NCT02226003 -
Efficacy and Safety of Ertugliflozin (MK-8835/PF-04971729) With Sitagliptin in the Treatment of Participants With Type 2 Diabetes Mellitus (T2DM) With Inadequate Glycemic Control on Diet and Exercise (MK-8835-017)
|
Phase 3 |